Cell-type specific expression of p11 controls cocaine reward

Biological Psychiatry

Volumn 76, Issue 10, 2014, Pages 794-801

  Arango Lievano, Margarita ^a   Schwarz, Justin T ^a   Vernov, Mary ^a   Wilkinson, Matthew B ^b   Bradbury, Kathryn ^b   Feliz, Akira ^a   Marongiu, Roberta ^a   Gelfand, Yaroslav ^a   Warner Schmidt, Jennifer ^c   Nestler, Eric J ^b   Greengard, Paul ^c   Russo, Scott J ^b   Kaplitt, Michael G ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cocaine reward; Conditional knock down; Nucleus accumbens; P11 (s100a10); Striatonigral pathway; Striatopallidal pathway

Indexed keywords

COCAINE; CRE RECOMBINASE; DOPAMINE 1 RECEPTOR; PROTEIN; PROTEIN C FOS; PROTEIN P11; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; VIRUS VECTOR; LIPOCORTIN 2; PROTEIN S 100; S100 CALCIUM BINDING PROTEIN A10;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; COCAINE DEPENDENCE; CONTROLLED STUDY; CORRELATIONAL STUDY; DOWN REGULATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; TITRIMETRY; ANIMAL; C57BL MOUSE; CONDITIONING; CYTOLOGY; DRUG EFFECTS; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PHYSIOLOGY;

ANIMALS; ANNEXIN A2; COCAINE; CONDITIONING (PSYCHOLOGY); DOWN-REGULATION; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURONS; NUCLEUS ACCUMBENS; RECEPTORS, DOPAMINE D1; REWARD; S100 PROTEINS;

EID: 84927909580     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2014.02.012     Document Type: Article

References (43)

1. Der-Avakian A, Markou A (2012): The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci 35:68-77
2. Kalivas PW, Volkow ND (2005): The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162:1403-1413
3. Hyman SE, Malenka RC, Nestler EJ (2006): Neural mechanisms of addiction: The role of reward-related learning and memory. Annu Rev Neurosci 29:565-598
4. Covington HE 3rd, Maze I, Sun H, Bomze HM, DeMaio KD, Wu EY, et al. (2011): A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron 71:656-670
5. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. (2003): The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 289: 3095-3105
6. Swendsen JD, Merikangas KR (2000): The comorbidity of depression and substance use disorders. Clin Psychol Rev 20:173-189
7. Grant BF (1995): Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey of adults. J Subst Abuse 7:481-497
8. Hyman SE, Malenka RC (2001): Addiction and the brain: The neurobiology of compulsion and its persistence. Nat Rev Neurosci 2: 695-703
9. Martin M, Chen BT, Hopf FW, Bowers MS, Bonci A (2006): Cocaine selfadministration selectively abolishes LTD in the core of the nucleus accumbens. Nat Neurosci 9:868-869
10. Koob GF, Volkow ND (2010): Neurocircuitry of addiction. Neuropsychopharmacology 35:217-238
11. Hikida T, Kimura K, Wada N, Funabiki K, Nakanishi S (2010): Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66:896-907
12. Lobo MK, Covington HE 3rd, Chaudhury D, Friedman AK, Sun H, Damez-Werno D, et al. (2010): Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 330: 385-390
13. Xu M, Guo Y, Vorhees CV, Zhang J (2000): Behavioral responses to cocaine and amphetamine administration in mice lacking the dopamine D1 receptor. Brain Res 852:198-207
14. Bertran-Gonzalez J, Bosch C, Maroteaux M, Matamales M, Herve D, Valjent E, Girault JA (2008): Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J Neurosci 28:5671-5685
15. Zhang L, Lou D, Jiao H, Zhang D, Wang X, Xia Y, et al. (2004): Cocaineinduced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 24: 3344-3354
16. Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, et al. (2006): Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 311:77-80
17. Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango- Lievano M, Ghose S, et al. (2010): Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med 2: 54ra76
18. Warner-Schmidt JL, Flajolet M, Maller A, Chen EY, Qi H, Svenningsson P, Greengard P (2009): Role of p11 in cellular and behavioral effects of 5-HT4 receptor stimulation. J Neurosci 29:1937-1946
19. Renigunta V, Yuan H, Zuzarte M, Rinne S, Koch A, Wischmeyer E, et al. (2006): The retention factor p11 confers an endoplasmic reticulumlocalization signal to the potassium channel TASK-1. Traffic 7:168-181
20. Foulkes T, Nassar MA, Lane T, Matthews EA, Baker MD, Gerke V, et al. (2006): Deletion of annexin 2 light chain p11 in nociceptors causes deficits in somatosensory coding and pain behavior. J Neurosci 26: 10499-10507
21. Warner-Schmidt JL, Schmidt EF, Marshall JJ, Rubin AJ, Arango-Lievano M, Kaplitt MG, et al. (2012): Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior. Proc Natl Acad Sci U S A 109:11360-11365
22. Morgenstern PF, Marongiu R, Musatov SA, Kaplitt MG (2011): Adenoassociated viral gene delivery in neurodegenerative disease. Methods Mol Biol 793:443-455
23. Russo SJ, Wilkinson MB, Mazei-Robison MS, Dietz DM, Maze I, Krishnan V, et al. (2009): Nuclear factor kappa B signaling regulates neuronal morphology and cocaine reward. J Neurosci 29:3529-3537
24. Tzschentke TM (2007): Measuring reward with the conditioned place preference (CPP) paradigm: Update of the last decade. Addict Biol 12: 227-462
25. Bardo MT, Bevins RA (2000): Conditioned place preference: What does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 153:31-43
26. Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A, et al. (2007): IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10:93-99
27. Koya E, Golden SA, Harvey BK, Guez-Barber DH, Berkow A, Simmons DE, et al. (2009): Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization. Nat Neurosci 12:1069-1073
28. Zhang J, Zhang L, Jiao H, Zhang Q, Zhang D, Lou D, et al. (2006): c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes. J Neurosci 26:13287-13296
29. Witten IB, Lin SC, Brodsky M, Prakash R, Diester I, Anikeeva P, et al. (2010): Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 330:1677-1681
30. Myslinski E, Ame JC, Krol A, Carbon P (2001): An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene. Nucleic Acids Res 29:2502-2509
31. Gong S, Doughty M, Harbaugh CR, Cummins A, Hatten ME, Heintz N, Gerfen CR (2007): Targeting Cre recombinase to specific neuron populations with bacterial artificial chromosome constructs. J Neurosci 27:9817-9823
32. Nelson AB, Hang GB, Grueter BA, Pascoli V, Luscher C, Malenka RC, Kreitzer AC (2012): A comparison of striatal-dependent behaviors in wild-type and hemizygous Drd1a and Drd2 BAC transgenic mice. J Neurosci 32:9119-9123
33. Hummel M, Unterwald EM (2002): D1 dopamine receptor: A putative neurochemical and behavioral link to cocaine action. J Cell Physiol 191: 17-27
34. Miner LL, Drago J, Chamberlain PM, Donovan D, Uhl GR (1995): Retained cocaine conditioned place preference in D1 receptor deficient mice. Neuroreport 6:2314-2316
35. Karasinska JM, George SR, Cheng R, O'Dowd BF (2005): Deletion of dopamine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation. Eur J Neurosci 22:1741-1750
36. Mathie A, Rees KA, El Hachmane MF, Veale EL (2010): Trafficking of neuronal two pore domain potassium channels. Curr Neuropharmacol 8:276-286
37. Okuse K, Malik-Hall M, Baker MD, Poon WY, Kong H, Chao MV, Wood JN (2002): Annexin II light chain regulates sensory neuron-specific sodium channel expression. Nature 417:653-656
38. Deora AB, Kreitzer G, Jacovina AT, Hajjar KA (2004): An annexin 2 phosphorylation switch mediates p11-dependent translocation of annexin 2 to the cell surface. J Biol Chem 279:43411-43418
39. Oh YS, Gao P, Lee KW, Ceglia I, Seo JS, Zhang X, et al. (2013): SMARCA3, a chromatin-remodeling factor, is required for p11- dependent antidepressant action. Cell 152:831-843
40. Hikida T, Kitabatake Y, Pastan I, Nakanishi S (2003): Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci U S A 100:6169-6173
41. Le Moine C, Tison F, Bloch B (1990): D2 dopamine receptor gene expression by cholinergic neurons in the rat striatum. Neurosci Lett 117:248-252
42. Aubry JM, Schulz MF, Pagliusi S, Schulz P, Kiss JZ (1993): Coexpression of dopamine D2 and substance P (neurokinin-1) receptor messenger RNAs by a subpopulation of cholinergic neurons in the rat striatum. Neuroscience 53:417-424
43. Paxinos G, Franklin K (2012): Paxinos and Franklin's the Mouse Brain in Stereotaxic Coordinates, 3rd ed. Waltham, MA: Academic Press.